Pharsight

Drug name - Copiktra

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8193182 SECURA Substituted isoquinolin-1(2H)-ones, and methods of use thereof
Feb, 2030

(7 years from now)

USRE46621 SECURA Processes for preparing isoquinolinones and solid forms of isoquinolinones
May, 2032

(9 years from now)

CN101965336A SECURA Certain Chemical Entities, Compositions And Methods
Jan, 2029

(6 years from now)

CN104926815A SECURA Some Real Chemistry, Composition And Method
Jan, 2029

(6 years from now)

CN104926815B SECURA Some Real Chemistry, Composition And Method
Jan, 2029

(6 years from now)

CN101965336B SECURA Chemistry, Composition And Method
Jan, 2029

(6 years from now)

CN101965335A SECURA Certain Chemical Entities, Compositions And Methods
Jan, 2029

(6 years from now)

CN101965335B SECURA Some Real Chemistry, Composition And Method
Jan, 2029

(6 years from now)

CN102711767B SECURA Some Real Chemistry, Composition And Method
Jul, 2030

(7 years from now)

CN106188059A SECURA Some Real Chemistry, Composition And Method
Jul, 2030

(7 years from now)

CN106188059B SECURA Certain Chemical Entities, Compositions And Method
Jul, 2030

(7 years from now)

CN102711767A SECURA Certain Chemical Entities, Compositions And Method
Jul, 2030

(7 years from now)

CN109912599A SECURA Chemical Entities, Compositions And Methods
Jul, 2030

(7 years from now)

CN109912599B SECURA Chemical Entities, Compositions And Methods
Jul, 2030

(7 years from now)

CN103648499A SECURA Preparation Method For Isoquinoline Ketone And Solid Form Of Isoquinoline Ketone
Jan, 2032

(9 years from now)

CN103648499B SECURA Preparation Method For Isoquinoline Ketone And Solid Form Of Isoquinoline Ketone
Jan, 2032

(9 years from now)

IN317213B SECURA A Compound Of Formula V-A Or V-B
Jan, 2029

(6 years from now)

IN201200943P1 SECURA Certain Chemical Entities, Compositions And Methods
Jul, 2030

(7 years from now)

EP2240451A1 SECURA Isoquinolinone Derivatives Substituted With A Purine Useful As Pi3K Inhibitors
Jan, 2029

(6 years from now)

EP2240452B1 SECURA 1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine Derivatives As Pi3 Kinase Modulators, Their Compositions And Uses
Jan, 2029

(6 years from now)

EP3613743A1 SECURA Processes For The Preparation Of 1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine Derivatives
Jan, 2029

(6 years from now)

EP2240451A4 SECURA Certain Chemical Entities, Compositions And Methods
Jan, 2029

(6 years from now)

EP2240452A1 SECURA 1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine Derivatives As Pi3 Kinase Modulators, Their Compositions And Uses
Jan, 2029

(6 years from now)

EP2240452A4 SECURA Certain Chemical Entities, Compositions And Methods
Jan, 2029

(6 years from now)

EP2240451B1 SECURA Isoquinolinone Derivatives Substituted With A Purine Useful As Pi3K Inhibitors
Jan, 2029

(6 years from now)

EP3613743B1 SECURA Processes For The Preparation Of 1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine Derivatives
Jan, 2029

(6 years from now)

EP3441392B1 SECURA A Pharmaceutical Composition For Oral Administration
Jul, 2030

(7 years from now)

EP3150609B1 SECURA Process For Preparing Certain Chemical Entities
Jul, 2030

(7 years from now)

EP2918589B1 SECURA Adenine Derivative As Pi3K Inhibitor
Jul, 2030

(7 years from now)

EP3150609A1 SECURA Process For Preparing Certain Chemical Entities
Jul, 2030

(7 years from now)

EP2918589A1 SECURA Adenine Derivative As Pi3K Inhibitor
Jul, 2030

(7 years from now)

EP3441392A1 SECURA A Pharmaceutical Composition For Oral Administration
Jul, 2030

(7 years from now)

EP2456444B1 SECURA Adenine Derivative As Pi3K Inhibitor
Jul, 2030

(7 years from now)

EP2456444A4 SECURA Certain Chemical Entities, Compositions And Methods
Jul, 2030

(7 years from now)

EP2456444A1 SECURA Adenine Derivative As Pi3K Inhibitor
Jul, 2030

(7 years from now)

EP2663309A4 SECURA Processes For Preparing Isoquinolinones And Solid Forms Of Isoquinolinones
Jan, 2032

(9 years from now)

EP3238722A1 SECURA Solid Forms Of Isoquinolinones
Jan, 2032

(9 years from now)

EP2663309B1 SECURA Processes For Preparing Isoquinolinones And Solid Forms Of Isoquinolinones
Jan, 2032

(9 years from now)

EP3238722B1 SECURA Solid Forms Of Isoquinolinones
Jan, 2032

(9 years from now)

EP2663309A1 SECURA Processes For Preparing Isoquinolinones And Solid Forms Of Isoquinolinones
Jan, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9216982 SECURA Certain chemical entities, compositions and methods Jan, 2029

(6 years from now)

US9840505 SECURA Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereof Jan, 2032

(9 years from now)

Drugs and Companies using DUVELISIB ingredient

Treatment: For the treatment of patients with follicular lymphoma (fl); for the treatment of patients with chronic lymphocytic leukemia (cll) and/or small lymphocytic leukemia (sll)

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
15MG CAPSULE;ORAL Prescription
25MG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.